中华移植杂志(电子版)2009年5月第3卷第2期ChinJTransplant(ElectronicEdition),May2009,Vol3,No.2·23·survivalinpatientswithend-stageliverdisease[J].Hepatology,2001,33:464-470.11DeschünesM,BelleSH,KromRA,etal.Earlyallograftdysfunctionafterlivertransplantation:adefinitionandpredictorsofoutcome.Na-tionalInstituteofDiabetesandDigestiveandKidneyDiseasesLiverTransplantationDatabase[J].Transplantation,1998,66:302-310.12GainzaFJ,ValdiviesoA,QuintanillaN,etal.Evaluationofacuterenalfailureinthelivertransplantationperioperativeperiod:inci-denceandimpact[J].TransplantProc,2002,34:250-251.13BusuttilRW,TanakaK.Theutilityofmarginaldonorsinlivertrans-plantation[J].LiverTranspl,2003,7:651-663.14NikeghbalianS,NejatollahiSM,SalahiH,etal.Doesdonorsfattyliverchangeimpactonearlymortalityandoutcomeoflivertransplan-tation[J].TransplantProc,2007,39:1181-1183.15KoneruB,DikdanG.Hepaticsteatosisandlivertransplantationcur-rentclinicalandexperimentalperspectives[J].Transplantation,2002,73:325-330.16TodoS,DemetrisAJ,MakowkaL,etal.Primarynonfunctionofhe-paticallograftswithpreexistingfattyinfiltration[J].Transplantation,1989,47:903-905.17BricenoJ,MarchalT,PadilloJ,etal.Influenceofmarginaldonorsonliverpreservationinjury[J].Transplantation,2002,74:522-526.18ChenH,PengCH,ShenBY,etal.Multi-factoranalysisofinitialpoorgraftfunctionafterorthotopiclivertransplantation[J].Hepato-biliaryPancreatDisInt,2007,6:141-146.19AdamR,ReynesM,JohannM,etal.Theoutcomeofsteatoticgraftsinlivertransplantation[J].TransplantProc,1991,23:1538-1540.20IjazS,YangW,WinsletMC,etal.Impairmentofhepaticmicrocir-culationinfattyliver[J].Microcirculation,2003,10:447-456.21SeifalianAM,PiaseckiC,AgarwalA,etal.Theeffectofgradedsteatosisonflowinthehepaticparenchymalmicrocirculation[J].Transplantation,1999,68:780-784.22FukumoriT,OhkohchiN,TsukamotoS,etal.Themechanismofin-juryinasteatoticlivergraftduringcoldpreservation[J].Transplan-tation,1999,67:195-200.23AvolioAW,AgnesS,NureE,etal.Thenonstandardliver,ahid-denresourcethatcannotbeoverlooked:implicationsfortheidentifi-cationofthebestrecipient[J].TransplantProc,2006,38:1055-1058.24AngeleMK,RentschM,HartlWH,etal.Effectofgraftsteatosisonliverfunctionandorgansurvivalafterlivertransplantation[J].AmJSurg,2008,195:214-220.25TekinK,ImberCJ,AtliM,etal.Asimplescoringsystemtoevalu-atetheeffectsofcoldischemiaonmarginalliverdonors[J].Trans-plantation,2004,77:411-416.(收稿日期:2009-01-13)(本文编辑:沈敏)本文文献引用格式:高峰,徐骁,凌琪,等.中度脂肪变性供肝肝移植的早期疗效与安全性研究[J/CD].中华移植杂志:电子版,2009,3(2):15-18.·学术动态·心脏移植后1年内外周内皮依赖的血管舒张功能的评估吴胜军李伟栋摘译自RoigE,CuppolettiA,MasottiM,etal.Assessmentofperipheralendothelial-dependentvasodilatationwithinthefirstyearafterhearttransplantation.JHeartLungTransplant,2009,28:299-304.心脏移植物血管病(CAV)是心脏移植后受者死亡的首要原因。有研究发现冠状血管内皮失功能(endothelialdysfunction,ED)现象是CAV的早期表现,在非移植受者中也发现了外周血管ED现象与冠脉血管失功现象之间有密切的相关性。因此,评价外周血管ED情况可能有助于判断早期CAV发生的风险。西班牙的研究者对40例心脏移植受者的前臂内皮依赖的血管反应性进行评估,分别在移植后1、6、12个月通过高分辨率肱动脉超声测量血流介导的血管舒张性(flow-mediatedvasodilatation,FMD),并在移植后1、12个月通过冠状动脉血管造影,移植后1年通过血管内超声检查来确定是否存在心脏CAV。结果发现,术后1个月的FMD均值是1.9%±2.6%,6个月时到增加到3.3%±3.2%(P<0.005),1年时上升到5.1%±3.4%(P<0.0001)。有33例(82%)患者FMD在术后1个月严重受损,27例(67%)在术后6个月时显示损伤严重,到术后1年时减少到19例(47%)。通过血管内超声发现,术后1年时19例确诊CAV。不存在外周ED现象的患者在术后1个月时的血管内膜增厚超过0.5mm的概率比存在ED现象的患者明显减少(20%比75%,P<0.01)。由此可见,心脏移植受者术后不久外周FMD损伤比较常见,而术后1年也有近50%的受者存在这种损伤。对于那些不存在外周ED现象的患者在术后1个月发生CAV的概率较低。(本文编辑:蒋婉洁)
